99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer

Summary

99mTc-QULIC-5-P1 is a new radiotracer targeting PSMA, which is promising as an excellent imaging agent applicable to PSMA positive prostate cancer. This study will investigate the safety, biodistribution and potential usefulness of 99mTc-QULIC-5-P1 SPECT imaging for the diagnosis of lesions in PSMA positive prostate cancer.

Timeline

Start

2024-05-20

Primary completion

2025-12-31

Completion

2026-12-31

Drugs

Indications